Viewing StudyNCT06635824



Ignite Creation Date: 2024-10-26 @ 3:42 PM
Last Modification Date: 2024-10-26 @ 3:42 PM
Study NCT ID: NCT06635824
Status: RECRUITING
Last Update Posted: None
First Post: 2024-10-08

Brief Title: Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer ABBIL1TY NSCLC-06
Sponsor: None
Organization: None

Conditions & Keywords Data

Conditions:
Keywords: